FIELD: medicine.
SUBSTANCE: invention relates to medicine and is intended for the prophylaxis of preeclampsia during pregnancy in women with mutation of Factor V Leiden (FVL) 1691, genotype G/A. When the normalized ratio of APC-resistance at the gestational age of 7–8 weeks is less than or equal to 0.49, sodium enoxaparin is administered subcutaneously 40 mg/day for 14 days.
EFFECT: method allows to reduce the incidence of preeclampsia and improve pregnancy outcomes in women with mutation of Factor V Leiden (FVL) 1691, genotype G/A.
1 cl, 2 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREECLAMPSIA PREDICTION IN PREGNANT WOMEN WITH MUTATION OF FACTOR V LEIDEN 1691 GENE OF G/A AND A/A GENOTYPE | 2016 |
|
RU2636228C1 |
| METHOD FOR PREDICTION OF SEVERE PREECLAMPSIA IN PREGNANT WOMEN ACCOMPANYING A MUTATION OF THE PROTHROMBIN GENE, GENOTYPE F2G20210A | 2019 |
|
RU2723627C1 |
| METHOD FOR PREVENTION OF PREECLAMPSIA IN CARRIERS OF F2G20210A MUTATION WITH SUPERTHRESHOLD INCREASE OF PROTHROMBIN ACTIVITY | 2019 |
|
RU2712444C1 |
| METHOD FOR DETERMINING THE DURATION OF THROMBOPROPHYLAXIS WITH LOW-MOLECULAR-WEIGHT HEPARIN AFTER ABDOMINAL DELIVERY IN CARRIERS OF THE LEIDEN MUTATION, GENOTYPE F5 G1691A | 2020 |
|
RU2752776C1 |
| METHOD FOR DETERMINING HIGH THROMBOGENIC RISK IN PREGNANCY FOR HEPARIN PREVENTION | 2014 |
|
RU2564945C1 |
| METHOD FOR PREDICTING EARLY PREECLAMPSIA ACCORDING TO THE LEVEL OF PROCOAGULANT ACTIVITY OF TISSUE FACTOR IN BLOOD PLASMA AT 19-21 WEEKS OF GESTATION IN PATIENTS OF THE LOW-RISK GROUP | 2022 |
|
RU2795083C1 |
| METHOD OF PREDICTING THE RECURRENCE OF EARLY SEVERE PREECLAMPSIA BASED ON THE RESULTS OF A STUDY OF THE LEVEL OF PLACENTAL MICROVESICLES IN BLOOD PLASMA IN PATIENTS WITH SEVERE PREECLAMPSIA IN A PERSONAL HISTORY | 2022 |
|
RU2798715C1 |
| METHOD FOR PREDICTION OF RISK OF DEGREE 2-3 CHRONIC PLACENTAL INSUFFICIENCY WITH FOETAL GROWTH DELAY SYNDROME IN PREGNANT WOMEN | 2013 |
|
RU2540928C1 |
| METHOD FOR PREVENTING PREECLAMPSIA IN PATIENTS WITH AN AGGRAVATED OBSTETRIC ANAMNESIS | 2016 |
|
RU2663593C2 |
| METHOD FOR PREDICTION OF RISK OF MALIGNANT GROWTHS IN FEMALE GENITAL ORGANS AND MAMMARY GLANDS | 2014 |
|
RU2578459C1 |
